Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Morgan Stanley (NY:MS)

202.42 -3.86 (-1.87%)
Official Closing Price Updated: 7:00 PM EDT, Sep 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Morgan Stanley

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Why J.B. Hunt Stock Dropped Today ↗
J.B. Hunt shares dropped more than 13% after CFO Brad Delco told a Morgan Stanley investor conference that Q3 earnings would fall 5% to 10% from Q2. 
Via The Motley Fool
Topics Energy Stocks
News headline image
The Fed Hiked Interest Rates for the First Time in 3 Years. Are AI Stocks in Trouble? ↗
Capital costs could rise alongside rising interest rates. 
Via The Motley Fool
Topics Artificial Intelligence Bonds Economy
News headline image
GEV Stock Jumps After GE Vernova CEO Touts This Milestone ↗
GE Vernova chief spoke of "strong and durable demand," as backlog grows. 
Via Investor's Business Daily
Topics Artificial Intelligence
News headline image
Freeport-McMoRan Eyes Leach Breakthrough, Bagdad Growth and Grasberg Recovery ↗
Freeport-McMoRan (NYSE:FCX) is pursuing growth through U.S. brownfield expansions, technology investments and the recovery of its Grasberg mine in Indonesia, President and CEO Kathleen Quirk said... 
Via MarketBeat
Topics Artificial Intelligence ETFs Economy
News headline image
Boeing Stock Skids As CEO Warns Of Further 737 Production Delays ↗
Boeing stock fell as much as 6% on Wednesday. 
Via Investor's Business Daily
News headline image
GE Vernova (GEV) Stock Is Up, What You Need To Know
What Happened? Shares of energy transition company GE Vernova (NYSE:GEV) jumped 4.5% in the afternoon session after the company projected strong backlog grow... 
Via StockStory
Topics Artificial Intelligence Initial Public Offering
News headline image
Boeing Eyes MAX 10 Certification as 737 Ramp, 777X Tests and Labor Vote Loom ↗
Boeing (NYSE:BA) executives said the company has made progress on commercial production, aircraft certification and defense-program execution, while continuing to work through supply-chain constraints,... 
Via MarketBeat
Topics Economy
News headline image
QuantumScape Ramps Pilot Line as Solid-State Battery Markets Expand ↗
QuantumScape (NYSE:QS) is focusing on ramping its automated pilot production line as it seeks to commercialize solid-state lithium-metal batteries for automotive customers and newly identified markets... 
Via MarketBeat
News headline image
The Dow, S&P 500, and Nasdaq Split Ahead of a Near-Certain Rate Hike ↗
The Fed is about to raise rates for the first time in three years. The dot plot matters more. 
Via The Motley Fool
Topics Artificial Intelligence Bonds Economy
News headline image
American Airlines Sees Strong Demand, but Fuel Spike Threatens Profit Outlook ↗
American Airlines Group (NASDAQ:AAL) CEO Robert Isom said demand remains strong across the carrier’s network, cabins and geographies, while volatile fuel costs remain the principal constraint on... 
Via MarketBeat
News headline image
S&P 500 Trucking Stock Craters On CFO's Warning ↗
J.B. Hunt warned of lower Q3 earnings amid surging fuel costs and higher yields. 
Via Investor's Business Daily
Topics Stocks
News headline image
GSK Targets Oncology Growth With Lung, Prostate and Gynecologic Cancer Pipeline ↗
GSK (NYSE:GSK) is pursuing a focused oncology expansion built around hematologic malignancies, gynecologic cancers, lung cancer, gastrointestinal cancers and prostate cancer, with a combination of... 
Via MarketBeat
Topics Intellectual Property
News headline image
One Wall Street Analyst Just Said Tesla Stock Could Be Worth $840: Time to Buy? ↗
The analyst update is not particularly significant on its own, but it helps highlight a Tesla business that deserves more attention. 
Via The Motley Fool
News headline image
Morgan Stanley Sees Wealth, AI Financing and Deal Rebound Powering Growth ↗
Morgan Stanley (NYSE:MS) Co-President Dan Simkowitz said the firm does not view 2026 as a peak-earnings year, citing growth opportunities in wealth management, a developing capital-markets recovery and... 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Honeywell Sees Strong Start as Pure-Play Automation Push Gains Momentum ↗
Honeywell International (NASDAQ:HON) Chairman and CEO Vimal Kapur said the company is seeing stronger-than-expected early-quarter momentum as it begins operating as a more focused automation business... 
Via MarketBeat
News headline image
Amgen Highlights MariTide, IMDELLTRA Pipeline Progress and Growth Priorities ↗
Amgen (NASDAQ:AMGN) outlined its growth priorities, late-stage pipeline progress and capital-allocation framework during a Morgan Stanley conference, as newly appointed Chief Financial Officer Thomas... 
Via MarketBeat
Topics ETFs
News headline image
Rivian Calls R2 Launch an Inflection Point as Demand, Autonomy Plans Accelerate ↗
Rivian Automotive (NASDAQ:RIVN) is entering what founder and CEO RJ Scaringe described as an “inflection point year,” as the electric-vehicle maker begins scaling its R2 midsize SUV and expands its... 
Via MarketBeat
Topics Supply Chain
News headline image
RTX Highlights $289B Backlog as Aerospace, Defense Demand Powers Growth ↗
RTX (NYSE:RTX) Chairman, President and CEO Chris Calio said the aerospace and defense company remains positioned to benefit from sustained commercial aviation and defense demand, citing a $289 billion... 
Via MarketBeat
News headline image
Medtronic Sees AI, Ablation and Targeted M&A Fueling Growth ↗
Medtronic (NYSE:MDT) Chief Financial Officer Thierry Piéton said the medical-device maker’s focus on acute procedures, expanding innovation pipeline and increased use of targeted acquisitions are... 
Via MarketBeat
Topics Artificial Intelligence
News headline image
General Motors Sees Q3 on Track as Truck Launch, Digital Growth Fuel 2027 Outlook ↗
General Motors (NYSE:GM) Chief Financial Officer Paul Jacobson said the automaker’s business is tracking consistently with its expectations for the third quarter, supported by resilient consumer... 
Via MarketBeat
Topics Economy World Trade
News headline image
Gilead Sciences Sees Yeztugo Powering HIV Growth as Oncology Pipeline Advances ↗
Gilead Sciences (NASDAQ:GILD) executives outlined plans to expand the company’s HIV prevention and treatment franchises while advancing oncology and inflammation programs, with Chairman and Chief... 
Via MarketBeat
Topics Intellectual Property
News headline image
AbbVie Maps Post-HUMIRA Growth With Apogee Deal, Immunology Pipeline ↗
AbbVie (NYSE:ABBV) executives outlined a pipeline and business-development strategy centered on immunology, neuroscience, oncology and obesity, while highlighting plans to expand beyond the company’s... 
Via MarketBeat
Topics ETFs
News headline image
Stocks making big moves yesterday: Corning, Baldwin Insurance Group, Gartner, Jabil, and Accenture
Check out the companies making headlines yesterday: Corning (NYSE:GLW): Glass and electronic component manufacturer Corning (NYSE:GLW) fell by 12.7% on Monda... 
Via StockStory
Topics Artificial Intelligence
Wall Street Sells the AI-Pause Weekend as Brent Punches Through $106 and the Ten-Year Cracks 5% for the First Time Since 2023 ↗
Via Chartmill
News headline image
Sarepta Sees ELEVIDYS Demand Stabilizing as FSHD, DM1 Readouts Near ↗
Sarepta Therapeutics (NASDAQ:SRPT) outlined plans to stabilize demand for its ELEVIDYS gene therapy while advancing RNA-based programs for facioscapulohumeral muscular dystrophy, or FSHD, and myotonic... 
Via MarketBeat
News headline image
Biogen Eyes Wave of Phase III Readouts as It Expands Beyond Neuroscience ↗
Biogen (NASDAQ:BIIB) is reshaping its business around a broader mix of neuroscience, immunology, kidney disease and ophthalmology assets, President and CEO Chris Viehbacher said during a Morgan Stanley... 
Via MarketBeat
News headline image
Viking Therapeutics Advances VK2735 Obesity Drug Into Phase 3 After 15% Weight Loss ↗
Viking Therapeutics (NASDAQ:VKTX) said its obesity drug candidate VK2735 has advanced into Phase 3 development following Phase 2 results that showed approximately 15% weight loss from baseline after 13... 
Via MarketBeat
News headline image
Regeneron Highlights Dupixent Growth, Cemdisiran Catalysts and EYLEA HD Momentum ↗
Regeneron Pharmaceuticals (NASDAQ:REGN) outlined growth opportunities for Dupixent, pipeline catalysts for cemdisiran and continued commercial momentum for EYLEA HD during the Morgan Stanley Global... 
Via MarketBeat
Topics Intellectual Property
News headline image
Teva Says Pivot to Growth Gains Steam as Branded Drugs, Biosimilars Outperform ↗
Teva Pharmaceutical Industries (NYSE:TEVA) CEO Richard Francis said the company has progressed from the initial phase of its “Pivot to Growth” plan into its next stage, citing momentum in branded... 
Via MarketBeat
Topics World Trade
News headline image
CRISPR Therapeutics Eyes CASGEVY Growth, Year-End Pipeline Catalysts ↗
CRISPR Therapeutics (NASDAQ:CRSP) CEO Sam Kulkarni outlined the company’s commercial and clinical priorities during a Morgan Stanley discussion, highlighting continued adoption of CASGEVY and expected... 
Via MarketBeat
Topics Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS